TLDR A new mouse model effectively mimics vitiligo for research and drug testing.
The study developed a mouse model for vitiligo that replicated key features of the disease, such as skin depigmentation and melanocyte loss, by activating endogenous autoreactive CD8+ T cells. This was achieved through the inoculation of B16F10 melanoma cells and depletion of CD4+ regulatory T cells. The model showed a 60-80% success rate in inducing depigmentation, with higher success in female mice, and was applicable to any C57BL/6 mouse strain. It provided a valuable tool for vitiligo research and drug discovery, allowing for the study of disease progression and potential therapeutic interventions.
43 citations
,
August 2018 in “Cell Stem Cell” Hoxc genes control hair growth through Wnt signaling.
60 citations
,
September 2004 in “Pediatric Dermatology” A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.
January 2012 in “heiDOK (Heidelberg University)” Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.
39 citations
,
June 2019 in “Toxins” Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.
6 citations
,
September 2022 in “Frontiers in pharmacology” Epimedium extract helps increase skin pigmentation and could be a new treatment for conditions with reduced pigmentation.
2 citations
,
May 2023 in “Photobiomodulation, photomedicine, and laser surgery” Light therapy is effective and safe for treating skin color disorders like vitiligo and dark spots.
January 2019 in “Springer eBooks” Combination therapies might work better for some vitiligo patients, but results vary.